此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

帕金森病SwallowFIT研究

"SwallowFit," 一项专为受帕金森病影响的美国军人、退伍军人及其家庭设计的运动计划与随机临床试验。

The goal of this clinical trial is to learn if a proactive swallow exercise will help to improve swallow fitness in patients with Parkinson's disease.

The aim of the study is to assess how effective this exercise is and to measure the change in swallowing fitness from the beginning to the end of the study.

Patients who are given the exercise training will be compared to participants who are treated using the usual standard treatment.

Patients will have 6 weeks of twice-weekly SwallowFIT training. Each session will be an hour long.

研究概览

地位

尚未招聘

详细说明

SwallowFIT: Subjects will receive 6-weeks of twice weekly SwallowFIT intervention per protocol (1-hour session each visit) from the BAMC speech language Pathologist (study SLP) at BAMC. Completion of the program will include 12 visits. The program is designed from a previous successful pilot trial. It begins with provision of general education on swallowing and swallowing change from the Parkinson's Foundation and Michael J Fox association websites.

Following this the program trains a modified effortful swallow technique at its onset using sEMG to guide the development of better swallow movement form, effort and performance. Once swallowing form is established, the program uses a hierarchy of swallowing tasks involving swallowing food/fluid materials at different complexity levels (swallow specificity) to stimulate and train progressive resistance and leverage variability of coordinated speeded actions.

Clinical Monitoring Only (CMO): This intervention mirrors the experimental intervention in all aspects, but the treatment type applied. CMO intervention reflects current swallow management practice for PD, where physicians monitor clinical function in swallowing and other related symptomology, referring for swallowing treatment only once an obvious issue has been identified.

研究类型

介入性

注册 (估计的)

80

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Texas
      • San Antonio、Texas、美国、78234-6200
        • Brooke Army Medical Center (BAMC)
        • 接触:
        • 接触:
          • Alexis Nelson
          • 电话号码:210-916-2203.

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

35年 至 90年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Adult S-VWP between >35-90 years of age
  2. Diagnosis of Idiopathic Parkinson's Disease [IDP] (either or suspected, tremor-predominant or rigid predominant)
  3. Disability level of Hoehn & Yahr stages II-III as indicated in their most recent neurological evaluation
  4. Swallowing concern, confirmed by Modified Unified Parkinson Disease Rating Scale [MDS-UPDRS]-
  5. ADL swallowing item >0, or Mann Assessment of Swallowing scale [MASA] score ≤185.
  6. Able to consume oral nutrition [Functional Oral Intake Score ≤ 6]
  7. Ambulatory
  8. No change of medication for at least 4 weeks before study inclusion

Exclusion Criteria:

  1. Classified as Hoehn and Yahr stages IV
  2. Unable to follow 2 step commands
  3. History of other neurological disease potentially causing dysphagia
  4. Dementia (MMSE<20; Montreal cognitive assessment (MoCA) ≤ 20)
  5. Severe depression (BDI>19)
  6. Severe dyskinesia of head and neck (resulting in problems with MBSS recording)
  7. Severe documented Gastrointestinal disease
  8. History of Gastro-esophageal surgery
  9. History of Head or neck cancer with swallowing impairment or surgical intervention
  10. History of breathing disorders or diseases (e.g., Asthma, chronic obstructive pulmonary disease (COPD) requiring assistive breathing support.
  11. Untreated hypertension
  12. Heart disease requiring restricted activity and medical intervention
  13. Speech therapy intervention for swallowing within the past three months
  14. Women who are pregnant, nursing, or who plan to become pregnant during the study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:SwallowFit Intervention

Subjects randomized to intervention will receive 6-weeks of twice weekly SwallowFIT per protocol (1-hour session each day). The program begins with provision of general education on swallowing and swallowing change from the Parkinson's Foundation and Michael J Fox association websites. Following this the program trains a modified effortful swallow technique at its onset using surface electromyographic (sEMG) biofeedback to guide the development of better swallow movement form, effort and performance. From there it applies a hierarchy of swallowing exercises/tasks involving swallowing food/fluid materials at different complexity levels (swallow specificity) to stimulate and train progressive resistance and leverage variability of coordinated speeded actions.

The SwallowFIT protocol follows an increasing task difficulty (levels on the hierarchy) and motor learning strategy. Progression on the hierarchy is guided and monitored by the occurrence of inefficiency markers in swallow wing (e.g. excessive lingual pumping, swallow hesitation, throat clearing etc.) confirmed from the baseline clinical and video fluoroscopic evaluations.

其他名称:
  • 吞咽练习
无干预:Clinical Monitoring Only (CMO)

CMO intervention reflects current swallow management practice for PD, where physicians monitor clinical function in swallowing and other related symptomology, referring for swallowing treatment only if an obvious issue has been identified. Subjects randomized to CMO will also receive general education on swallowing and swallow changes from the Parkinson's Foundation and Michael J Fox association websites.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Mann Assessment of Swallowing Ability (MASA)
大体时间:Baseline to 6 months

The MASA score is measured using a 5-point to 10-point rating scale. The total possible score of the MASA is 200 points, and the cutoff value is 177 points. The results of the MASA are interpreted as no abnormality (≥178), mild dysphagia (168-177), moderate dysphagia (139-167), and severe dysphagia (≤138).

Baseline to 6 months
Modified Unified Parkinson Disease Rating Scale (MDS-UPDRS)
大体时间:Baseline to 6 months

The MDS-UPDRS uses a 0-4 scoring system, with higher scores indicating more severe symptoms. Parts I-III are scored on a 0-4 scale, while Part IV uses "yes" and "no" ratings. The total score range is 0-260, with 0 representing no disability and 260 representing total disability.

Baseline to 6 months
Modified Hoehn and Yahr (HY) Scale
大体时间:Baseline to 6 months

The Hoehn and Yahr (H&Y) scale is a grading system used to assess the progression and severity of motor symptoms in Parkinson's disease (PD). It ranges from Stage 0 (no signs of disease) to Stage 5 (severe disability, wheelchair or bed bound). Stages 1, 1.5, 2, and 2.5 are considered early stages, while stages 3, 4, and 5 represent later, more advanced stages.

Baseline to 6 months
Montreal Cognitive Assessment (MoCA)
大体时间:Baseline to 6 months

The Montreal Cognitive Assessment (MoCA) is a cognitive screening tool with a maximum score of 30 points, with a score of 26 or higher generally indicating normal cognitive function. Scores between 18 and 25 may suggest mild cognitive impairment (MCI), while scores below 18 may indicate moderate to severe impairment.

Baseline to 6 months
PD Quality of Life Scale (PDQ-39)
大体时间:Baseline to 6 months

The PDQ-39 is a questionnaire used to assess the impact of Parkinson's disease on quality of life. It consists of 39 questions, each rated on a 5-point scale from 0 (never) to 4 (always). Scores for the 39 questions are added to obtain a total score.

The scores for the 8 subscales (mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and physical discomfort) are obtained by summing the scores for the relevant questions within each subscale.

The total score and subscale scores range from 0 to 100, with higher scores indicating a greater impact of Parkinson's disease on quality of life.

Baseline to 6 months

次要结果测量

结果测量
措施说明
大体时间
Modified Barium Swallowing Impairment Profile, overall impression score (MBSImp OI score)
大体时间:Baseline to 6 months

In the context of the Modified Barium Swallow Impairment Profile (MBSImP), Overall Impression (OI) scoring is the most common method used to assess swallowing physiology. It involves assigning a score to each of the 17 physiological components based on the most severe impairment observed across different swallowing tasks. These scores range from 0 to 4 depending on the component, and total scores range from 0-68 with higher scores indicating greater impairment.

Baseline to 6 months
Spontaneous Swallowing Frequency (SSF)
大体时间:Baseline to 6 months

Spontaneous swallowing frequency (SSF) scoring refers to counting the number of times a person swallows without any specific prompting or external stimuli. It's a method used to assess swallowing function, particularly in conditions like dysphagia (difficulty swallowing), and can be a tool for screening and evaluating swallowing problems. A 5-10 minute sampling window is often used to calculate SSF.

Healthy Swallowing:

In healthy individuals, spontaneous swallowing typically occurs at a rate of 1-2 swallows per minute.

Dysphagia:

Patients with dysphagia often have a reduced SSF compared to healthy individuals.

Thresholds:

Some studies have suggested a threshold of 0.40 swallows per minute as a potential indicator of significant dysphagia.

Baseline to 6 months
Penetration Aspiration Scale (PAS)
大体时间:Baseline to 6 months

The Penetration-Aspiration Scale (PAS) is an 8-point scale used to assess the depth and response to airway invasion during swallowing. It helps clinicians and researchers understand the severity of swallowing dysfunction by categorizing the location of the bolus within the airway and whether it's expelled or not. The scale is used in videofluoroscopic swallowing studies (VFSS) to quantify swallowing event. A score of 1 would indicate no material entered the airway while a score of 8 would indicate the most amount of material aspirated during swallowing.

Baseline to 6 months
Analysis of Swallowing Physiology: Events, Kinematics and Timing (ASPEKT)
大体时间:Baseline to 6 months

Method of measuring physiologic kinematics and timing for swallowing images retrieved from modified barium swallow (MBSS). It evaluates of 8 key parameters of swallowing taken by frame analysis on open-source NIH, Image J software. Scoring of kinematic swallow movements will be evaluated using the published protocol

Baseline to 6 months
Functional Oral Intake Scale (FOIS)
大体时间:Baseline to 6 months

The Functional Oral Intake Scale (FOIS) is a 7-point ordinal scale used to assess a patient's ability to swallow and eat safely and efficiently. Scores range from 1 to 7, with higher scores indicating better swallowing function and a greater ability to participate in oral intake.

Baseline to 6 months
Lingual Pressure/movement
大体时间:Baseline to 6 months

The Lingual Pressure Movement Scale, part of the AIMS (Abnormal Involuntary Movement Scale), assesses the severity of tongue movements. It uses a 0-4 scale, where 0 represents no movement, 1 represents minimal movement (may be extreme normal), 2 represents mild movement, 3 represents moderate movement, and 4 represents severe movement.

Baseline to 6 months
Sydney Swallowing Questionnaire (SSQ)
大体时间:Baseline to 6 months

The Sydney Swallow Questionnaire (SSQ) is scored by summing the individual scores for each question. It consists of 17 questions, with most questions scored on a visual analog scale (VAS), ranging from 0 to 100 mm. The total possible score is 1700. Higher scores indicate more severe swallowing difficulties.

Baseline to 6 months
Protocol Adherence Measure
大体时间:Baseline to 6 months

Percentage attendance measured by number of prescribed exercise sessions completed

Baseline to 6 months
Patient Perception of Swallowing (VAS)
大体时间:Baseline to 6 months

In patient perception of swallowing, a Visual Analogue Scale (VAS) is used to assess a patient's subjective experience of swallowing difficulties. Patients mark a point on a line (typically 100 mm) that represents the severity of their swallowing problem, with 0 indicating no trouble and 100 indicating a total inability to swallow.

Baseline to 6 months
Patient/Caregiver Acceptability/Satisfaction Scale (PA/SS)
大体时间:Baseline to 6 months

A 5 item scale where each item is scored on a Likert scale from 0-10. Total scores range from 0-50 with a higher score indicating that the SwallowFIT program was more helpful.

Baseline to 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Giselle Carnaby, PhD, MP、The University of Texas Health Science Center at San Antonio

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月30日

初级完成 (估计的)

2028年3月30日

研究完成 (估计的)

2028年6月29日

研究注册日期

首次提交

2026年1月12日

首先提交符合 QC 标准的

2026年1月12日

首次发布 (实际的)

2026年1月21日

研究记录更新

最后更新发布 (实际的)

2026年10月6日

上次提交的符合 QC 标准的更新

2026年10月5日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

其他研究编号

  • STUDY00001444
  • FY24 HT942524PRPIIRA (其他赠款/资助编号:Department of Defense)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

The study team will report and publish in a peer-reviewed journal (trials journal) the study protocol and proposed analysis, to provide similar information to the national and international scientific community.

Information provision and awareness-raising will take place during project inception and intensify as results become available.

Study results will be published and displayed on the project webpage following completion of the 6 month follow up of all subjects.

IPD 共享时间框架

After the study is complete and unblinded, the study team will submit all remaining scientific data to the data repository, and we will update the study status to "completed" in clinical trials.gov. According to the study timeline, all generated scientific data will approximately coincide with the submission of the results to clinicaltrials.gov and will occur no later than by the end of award. Scientific data included in published manuscripts will be available at the time of publication. According to the proposed project timeline, all generated scientific data will approximately coincide with the submission of the results to clinicaltrials.gov at the end of the award, and full data sharing (via repository) will occur no later than six months after completion of the study or acceptance for publication of the main findings from the final dataset.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅